Guardant Health, Inc. (GH)
165.22
+2.23
(+1.37%)
USD |
NASDAQ |
Oct 15, 12:57
Guardant Health Enterprise Value : 22.42B for Oct. 14, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 14, 2026 | 22.42B |
| October 13, 2026 | 22.30B |
| October 12, 2026 | 22.39B |
| October 09, 2026 | 23.02B |
| October 08, 2026 | 22.76B |
| October 07, 2026 | 23.13B |
| October 06, 2026 | 23.45B |
| October 05, 2026 | 25.66B |
| October 02, 2026 | 24.40B |
| October 01, 2026 | 23.99B |
| September 30, 2026 | 24.47B |
| September 29, 2026 | 24.39B |
| September 28, 2026 | 24.34B |
| September 25, 2026 | 24.33B |
| September 24, 2026 | 24.22B |
| September 23, 2026 | 24.20B |
| September 22, 2026 | 24.31B |
| September 21, 2026 | 23.87B |
| September 18, 2026 | 24.61B |
| September 17, 2026 | 25.11B |
| September 16, 2026 | 24.01B |
| September 15, 2026 | 24.11B |
| September 14, 2026 | 23.07B |
| September 11, 2026 | 21.67B |
| September 10, 2026 | 21.89B |
| Date | Value |
|---|---|
| September 09, 2026 | 22.39B |
| September 08, 2026 | 22.15B |
| September 04, 2026 | 22.21B |
| September 03, 2026 | 22.16B |
| September 02, 2026 | 22.43B |
| September 01, 2026 | 22.61B |
| August 31, 2026 | 21.89B |
| August 28, 2026 | 22.22B |
| August 27, 2026 | 23.16B |
| August 26, 2026 | 23.48B |
| August 25, 2026 | 22.68B |
| August 24, 2026 | 22.45B |
| August 21, 2026 | 23.45B |
| August 20, 2026 | 23.07B |
| August 19, 2026 | 22.47B |
| August 18, 2026 | 22.04B |
| August 17, 2026 | 22.24B |
| August 14, 2026 | 21.65B |
| August 13, 2026 | 21.96B |
| August 12, 2026 | 22.70B |
| August 11, 2026 | 22.70B |
| August 10, 2026 | 22.98B |
| August 07, 2026 | 23.15B |
| August 06, 2026 | 21.70B |
| August 05, 2026 | 22.45B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Natera, Inc. | 55.84B |
| Quest Diagnostics, Inc. | 31.82B |
| Labcorp Holdings, Inc. | 32.31B |
| OPKO Health, Inc. | 1.119B |
| Psychemedics Corp. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -120.14M |
| Revenue (Quarterly) | 334.98M |
| Total Expenses (Quarterly) | 455.12M |
| EPS Diluted (Quarterly) | -0.9042 |
| Gross Profit Margin (Quarterly) | 65.39% |
| Profit Margin (Quarterly) | -35.87% |
| Earnings Yield | -2.12% |
| Normalized Earnings Yield | -2.072 |